{
    "title": "GSK vows to stick by controversial diabetes drug",
    "url": "https://www.dailymail.co.uk/money/article-1309633/GSK-vows-stick-controversial-diabetes-drug.html",
    "date": "2010-09-06",
    "keywords": [
        "drug",
        "avandia",
        "heart",
        "gsk",
        "risk",
        "market",
        "september",
        "sale",
        "regulator",
        "treatment",
        "failure",
        "agency",
        "use",
        "meeting",
        "spokesman",
        "firm",
        "year",
        "licence",
        "history",
        "rob",
        "mail",
        "gmt",
        "view",
        "smithkline",
        "blockbuster",
        "unfit",
        "seller",
        "study",
        "healthcare",
        "mhra",
        "blow",
        "rosiglitazone",
        "statement",
        "faller",
        "footsie",
        "mhrasaid",
        "longer",
        "place",
        "future",
        "tomorrow",
        "share",
        "price",
        "stock",
        "thisismoneycouk",
        "bp",
        "asset",
        "bid",
        "deepwater",
        "horizon",
        "disaster",
        "food",
        "administration",
        "exclusivity",
        "ema",
        "decision",
        "citigroup",
        "withdrawal",
        "debate",
        "emas",
        "ruling",
        "europe",
        "anyone",
        "complaint",
        "merrill",
        "lynch",
        "problem",
        "brokerage",
        "litigation",
        "secondquarter"
    ],
    "category": [
        "money"
    ]
}